Navigation Links
Advanced Medical Specialties Joins US Oncology Network
Date:1/24/2008

the more than 1,100 oncologists in their national network. Working with the network to create and to share best practices will drive further progress in the fight against cancer and be of great benefit to our patients," said Dr. Oscar Tercilla, M.D., a radiation oncologist at AMS and a member of its Board of Managers.

Physician members of the US Oncology network have the opportunity to actively engage in a variety of national committees and working groups, much like an oncology think tank, to share and to create new and improved clinical and operational processes that advance the delivery of cancer care for their patients.

One specific physician-led initiative resulting from that collaboration is the development and implementation of an evidence-based approach to cancer care called Cancer Care Pathways. Pathways improve the quality of treatment decision making for all patients by providing physicians with up-to-date information on the clinical evidence supporting the use of various therapies.

Often, the need for new services and resources also result from the physician committees. One example is the company's efforts to improve the efficiency and safety of drug acquisition, management and delivery. Last year the company became the first oncology distributor to launch an ePedigree drug tracking system that tracks drugs, from the manufacturer to patient, helping to protect the integrity of the drug and improve overall safety. The company also launched a national oral oncology pharmacy to provide needed services to patients and practices in the emerging area of oral therapies.

US Oncology Research, one of the nation's largest community-based cancer research networks, is a 500-physician research network that provides many opportunities to offer patients the latest therapies in development, from Phase I - Phase IV trials. It has also played a pivotal role in the development of 24 of the last 30 cancer therapeutics approved by the FDA.


'/>"/>

SOURCE US Oncology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development
2. Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
3. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
4. Advanced Energy Consortium will develop micro and nanosensors to boost energy production
5. Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
6. Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference
7. Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
8. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
9. Advanced Life Sciences Enters Into Definitive Securities Purchase Agreements for $20 Million with New and Existing Institutional Investors
10. Young Physicians Demanding Advanced Laparoscopic Energy Instruments
11. Model for the assembly of advanced, single-molecule-based electronic components developed at Pitt

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...SSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSci...uctdevelopmentcompanythatidentifiesandadvancesadiv...riousstagesofdevelopment,todayreportedthatCytopia(...luatingCYT387,apotent,orally-administeredJAK1/JAK2...chester,Minnesota.AproposaltomergeCytopiaintoYMhas...
(Date:11/23/2009)...ATTLE,Nov.23/PRNewswire/--ImmuneDesignC or p.(IDC)...ExecutiveChairman.Dr.Carterhasasuccessfultrackrec ...r merChiefExecutiveOfficeratZymoGenetics,inSeattle...agen,Denmark. ,, (Photo: http://www.newscom.com...ed,IDC,sfounderandChiefExecutiveOfficercommented,"...
(Date:11/23/2009)...DWOODCITY,Calif.,Nov.23/PRNewswire/--PearlTherapeu...euticproductsforthetreatmentofchronicrespiratorydi...hecompany,sBoardofDirectors.Mr.Rosenhas25yearsofex...ies,includingkeyrolesatGileadSciencesandALZACorpor...nPearl,sBoardtosix. ,, "Howiebringsawealthofpro...
(Date:11/20/2009)...d Latin American countries have an opportunity to ...Researchers from the University of Valencia (UV), ... studied the productive fabric of the Spanish biot...,s food and plant sectors have more clout than tho...y as applied to food and plants has been overlooke...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2
..., Oct. 24 SenesTech, Inc. has initiated,field tri...sland of Java in,continuing research collaboration... Dr. Grant Singleton of the International Rice,Res...ta Mayer and Cheryl,Dyer of SenesTech, Inc. will j...cientific and Industrial Research Organisation (CS...
...t. 24 The Committee for,Medicinal Products for Hu...MEA) has adopted a negative opinion on a Cymbalta(...treatment of fibromyalgia., "Eli Lilly and Compan...ted by the CHMP,s opinion," said James Russell, M....lly and Company. "We remain,confident in the dulox...
...24 Favrille, Inc. (OTC,Bulletin Board: FVRL) anno... term sheet for a reverse merger whereby Favrille ...e company, MyMedicalRecords.com, Inc.,("MMR"), in ...becoming a,wholly-owned subsidiary of Favrille. If...rms set forth in the non-binding term sheet, at th...
Other Biology Technology:SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia 2European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 2European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 3European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 4European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 5Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction 2
(Date:11/23/2009)...ire microbiologist Louis Tisa has received two gra...the actinorhizal plants, widespread woody plants w...ated soils. , The United States Department of A...ecular, cellular and biomedical sciences, $399,000... bacteria Frankia and Casuarina, an actinorhizal p...
(Date:11/23/2009)...edical engineer and cardiologist Tzung "John" Hsia...istinguish cardiac emergencies requiring immediate...gs and lifestyle change. , Angiograms, images ma... the heart, offer an inside view of the interior s...ealing deposits of a dangerous fatty substance cal...
(Date:11/23/2009)...sted for 360 million years and survived when the d...tening to make many of them extinct, according to ...Today . , The fungus, Batrachochytrium dendrob...s of amphibian extinctions in Central America and ...over 350 amphibian species by penetrating their sk...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 1Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 2Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 3Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 4Discovery could improve hepatitis C treatment 58129 1Discovery could improve hepatitis C treatment 58129 2InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 1InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 2
..., A collaboration between more than 70 researcher... the X chromosome that, when knocked-out, lead to ...ied almost all X chromosome genes in 208 families ... this type ever reported. , Remarkably, the team...omosome genes, when knocked-out, have no apparent ...
..., SALT LAKE CITY As the U.S. Southwest grew war... vanished from what is now the Mojave Desert, robb...ty of Utah biologists have narrowed the hunt for d... creosote bushes that replaced juniper. , "It wa...or Denise Dearing, senior author of the study, pub...
..., , As the U.S. Southwest grew warmer between 18,7...om what is now the Mojave Desert, robbing woodrats...rrowed the hunt for detoxification genes that let ...laced junipers. , "It was either eat it or move o...ty of Utah, lead author of a paper detailing the r...
Other Biology News:The genetic X-factor 2The genetic X-factor 3Poison: It's what's for dinner 2Poison: It's what's for dinner 3Poison: It's what's for dinner 4Poison: It's what's for dinner 5Desert woodrats switch one dietary poison for another 2
...y scanner based on patented confocal laser imaging...patial resolution. The DNAscope LM is unique beca...t is upgradeable to a total of 3 laser excitation ... (computer), monitor, and software easy to use ...
...ures an ultra-thin nitrocellulose coating for mult...rst protein microarray slide to provide the many b...background fluorescence providing excellent signal...ed for a variety of assays, such as sandwich immun...
Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
...Alkaline Phosphatase conjugates. The product insu...the enzyme and the antibody following long-term st...emically engineered to increase conjugate stabilit...stance to various shipping conditions and storage ...
Biology Products: